Literature DB >> 2727902

The effects of hyperoxia during fulminant sepsis.

W L Garner1, J B Downs, T E Reilley, D Frolicher, A Kargi, P J Fabri.   

Abstract

Although adequate tissue oxygenation is essential to maintain cellular metabolism, the use of hyperoxia to improve oxygen delivery or to improve metabolic performance is controversial. For example, supplemental inspired oxygen is reportedly beneficial in the treatment of some experimental infections; however, oxygen therapy also has well-documented adverse side effects. To evaluate the effect of increased inspired oxygen concentration (FIO2) in animals with fulminant sepsis, 117 Sprague-Dawley rats underwent cecal ligation and puncture. Animals were then exposed to an FIO2 of either 0.21, 0.4, or 0.8. Twenty sham-operated controls had no mortality with any FIO2. Increasing the FIO2 increased mortality from 70% to 85% in animals receiving 40% O2, and to 100% in those receiving 80% O2. Autopsies revealed mild pulmonary oxygen toxicity with 80% O2 exposure in both control and septic animals, but normal lung histologic appearance in animals receiving lower levels of oxygen. Arterial blood gases documented maintenance of oxygenation and ventilation. Thus, pulmonary oxygen toxicity does not appear to be the mechanism for increased mortality. Supplemental oxygen may worsen, rather than improve, survival after fulminant infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2727902

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

1.  Is it time to change the approach to oxygen therapy in the breathless patient?

Authors:  Richard Beasley; Sarah Aldington; Geoffrey Robinson
Journal:  Thorax       Date:  2007-10       Impact factor: 9.139

2.  Oxygen therapy for sepsis and prevention of complications.

Authors:  Hayk Minasyan
Journal:  Acute Crit Care       Date:  2022-03-17

3.  The impact of inspired oxygen concentration on tissue oxygenation during progressive haemorrhage.

Authors:  Alex Dyson; Ray Stidwill; Val Taylor; Mervyn Singer
Journal:  Intensive Care Med       Date:  2009-07-18       Impact factor: 17.440

Review 4.  Clinical review: Acute respiratory distress syndrome - clinical ventilator management and adjunct therapy.

Authors:  Jonathan A Silversides; Niall D Ferguson
Journal:  Crit Care       Date:  2013-04-29       Impact factor: 9.097

Review 5.  Animal models of acute lung injury.

Authors:  Gustavo Matute-Bello; Charles W Frevert; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.